Activin and Inhibin

Glyoxalase I inhibitor (free base) is a potent Glyoxalase I (GLO1) inhibitor, candidate for anticancer agents.Form:Solid.

Glyoxalase I inhibitor (free base) is a potent Glyoxalase I (GLO1) inhibitor, candidate for anticancer agents.Form:Solid.

Glyoxalase I inhibitor (free base) is a potent Glyoxalase I (GLO1) inhibitor, candidate for anticancer agents.Form:Solid.

Glyoxalase I inhibitor (free base) is a potent Glyoxalase I (GLO1) inhibitor, candidate for anticancer agents.

GlyRS-IN-1 is a glycyl-tRNA synthase ( GlyRS ) inhibitor extracted from patent WO 2017066459 A1. GlyRS-IN-1 can also inhibit the growth of bacteriaForm:SolidIC50&amp: Target:GlyRS, Bacterial.

GlyRS-IN-1 is a glycyl-tRNA synthase ( GlyRS ) inhibitor extracted from patent WO 2017066459 A1. GlyRS-IN-1 can also inhibit the growth of bacteriaForm:SolidIC50&amp: Target:GlyRS, Bacterial.

GlyT1 Inhibitor 1 is a potent and selective GlyT1 inhibitor with an IC 50 of 38 nM for rGlyT1 Antipsychotic activityIn VivoGlyT1 Inhibitor 1 (Compound 46) demonstrates in vivo efficacy in a rat novel object recognition (NOR) assay after oral dosing

GlyT1 Inhibitor 1 is a potent and selective GlyT1 inhibitor with an IC 50 of 38 nM for rGlyT1 Antipsychotic activityIn VivoGlyT1 Inhibitor 1 (Compound 46) demonstrates in vivo efficacy in a rat novel object recognition (NOR) assay after oral dosing

GlyT1 Inhibitor 1 is a potent and selective GlyT1 inhibitor with an IC 50 of 38 nM for rGlyT1 Antipsychotic activityIn VivoGlyT1 Inhibitor 1 (Compound 46) demonstrates in vivo efficacy in a rat novel object recognition (NOR) assay after oral dosing

GlyT1 Inhibitor 1 is a potent and selective GlyT1 inhibitor with an IC 50 of 38 nM for rGlyT1 Antipsychotic activityIn VivoGlyT1 Inhibitor 1 (Compound 46) demonstrates in vivo efficacy in a rat novel object recognition (NOR) assay after oral dosing

GN25 is a specific p53-Snail binding inhibitor with antitumor effects.In VitroGN25 (10 and 20 μM: 24 h) inhibits cell viability of K-Ras-mutated MEF cells. GN25 (5 μM: 4 h) activates p53 in a K-Ras-dependent manner. GN25 (1-10 μM: 1-6 h) induces p53

GN25 is a specific p53-Snail binding inhibitor with antitumor effects.In VitroGN25 (10 and 20 μM: 24 h) inhibits cell viability of K-Ras-mutated MEF cells. GN25 (5 μM: 4 h) activates p53 in a K-Ras-dependent manner. GN25 (1-10 μM: 1-6 h) induces p53